Table 5.

Effect of IP indomethacin and lipopolysaccharide alone, as well as their combined administration on SWD number (Figure 3, group 2–4).

Treatments (Figure 3; groups 2–4)	SWD number (mean ± S.E.M.; significance level/p-value)
	30–90 min	90–150 min
Control	17.9 ± 0.306	17.3 ± 0.189
Indomethacin	6.0 ± 0.436 ****/<0.0001	8.4 ± 0.297 ****/<0.0001
Control	18.5 ± 0.413	18.7 ± 0.457
LPS	40.6 ± 1.757 ****/<0.0001	57.4 ± 2.419 ****/<0.0001
Control	17.6 ± 0.408	17.8 ± 0.233
Indomethacin + LPS	16.9 ± 0.488 –/0.6321	17.6 ± 0.528 –/0.9773

LPS, lipopolysaccharide; SWD, spike-wave discharge.

^****p < 0.0001.